camonsertib,Niraparib,Olaparib,Talazoparib
repare therapeutics,roche,gsk,astrazeneca,merck,pfizer
['tresr', 'camonsertib', 'repare therap', 'repare,(-prepare)']
today at #aacr23 clinical trials plenary session, repare disclosed initial data from our ongoing phase 1/2 tresr and attacc clinical trials evaluating camonsertib in combination with three parp inhibitors in patients with #solidtumors. full presentation: 
Repare is a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics.